Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -133,978 | -96,483 | -72,415 | -36,034 | -37,938 |
| Depreciation Amortization | 14,951 | 11,424 | 7,649 | 3,856 | 16,551 |
| Accounts receivable | 20,164 | 12,188 | 16,642 | 22,942 | -20,301 |
| Accounts payable and accrued liabilities | -3,384 | -4,200 | -3,149 | -2,895 | 4,274 |
| Other Working Capital | -14,959 | -1,937 | 4,806 | 12,197 | -64,657 |
| Other Operating Activity | 3,464 | 7,480 | -3,191 | -14,936 | 46,200 |
| Operating Cash Flow | $-113,742 | $-71,528 | $-49,658 | $-14,870 | $-55,871 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -102,230 | N/A | N/A | N/A | N/A |
| PPE Investments | -9,722 | -8,294 | -6,845 | -3,765 | -31,457 |
| Purchase Of Investment | N/A | -627,529 | -509,681 | -372,723 | -443,122 |
| Sale Of Investment | N/A | 509,470 | 337,440 | 174,603 | 491,292 |
| Investing Cash Flow | $-111,952 | $-126,353 | $-179,086 | $-201,885 | $16,713 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -1,978 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | -1,431 | -934 | -459 | -1,356 |
| Common Stock Issued | 224,313 | 224,072 | 223,549 | 221,958 | 8,891 |
| Financing Cash Flow | $222,335 | $222,641 | $222,615 | $221,499 | $7,535 |
| Exchange Rate Effect | 916 | 493 | N/A | -14 | -219 |
| Beginning Cash Position | 17,755 | 17,755 | 17,755 | 17,755 | 49,597 |
| End Cash Position | 15,312 | 43,008 | 11,626 | 22,485 | 17,755 |
| Net Cash Flow | $-2,443 | $25,253 | $-6,129 | $4,730 | $-31,842 |
| Free Cash Flow | |||||
| Operating Cash Flow | -113,742 | -71,528 | -49,658 | -14,870 | -55,871 |
| Capital Expenditure | -9,722 | -8,294 | -6,845 | -3,765 | -31,457 |
| Free Cash Flow | -123,464 | -79,822 | -56,503 | -18,635 | -87,328 |